<DOC>
	<DOCNO>NCT01279252</DOCNO>
	<brief_summary>The purpose study evaluate whether patient previously untreated , early stage CLL respond empirical broad spectrum antibiotic therefore test hypothesis occult bacterial infection involve induction maintenance CLL .</brief_summary>
	<brief_title>CLL Empirical Antibiotic Regimen</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Age &gt; 18 ECOG performance status 2 less . CLL diagnostic score 4 5 . Clinical stage A disease . No disease progression minimum 1 month prior commencement therapy . Less 2 adverse prognostic factor . Absence adverse cytogenetics . Expected survival &gt; 6 month . Able give inform consent . No clinical evidence active infection time study entry . No know allergy study medication . Renal liver function test within normal limit . Disease progression screen period . Known positivity HIV type 1 2 . Active infection time screen . Pregnancy lactation . Females childbearing potentialâ€  male willing practice effective method contraception whilst receive antibiotic regimen 4 week last dose . Concomitant medication likely produce serious interaction study drug include warfarin type oral anticoagulant antiepileptic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>